Related Experiment Video
Updated: Aug 28, 2026
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Systemic AA Amyloidosis Following Immune Checkpoint Inhibitor Therapy for Lung Carcinosarcoma: An Autopsy Case and
Shinobu Onishi1, Sari Iwasaki1, Shimpei Nakagawa1
1Department of Pathology, Faculty of Medicine, Hokkaido University, Japan.
Abstract:
AA amyloidosis is a rare but serious complication of chronic inflammation. We report an autopsy case of a 68-year-old man without a documented history of inflammatory disease who developed lung carcinosarcoma and achieved a durable complete response after sequential immune checkpoint inhibitor (ICI) therapy. Despite tumor control, the patient developed a chronic intestinal pseudo-obstruction, persistent C-reactive protein elevation, progressive renal dysfunction, and later aspiration pneumonia. Autopsy revealed systemic AA amyloid deposition, predominantly in the intestines and kidneys, chronic thyroiditis, and tubulointerstitial nephritis. This case raises the possibility that prolonged inflammation during and after ICI therapy contributes to systemic AA amyloidosis.
